Cargando…
Residual tissue repositories as a resource for population-based cancer proteomic studies
BACKGROUND: Mass spectrometry-based proteomics has become a powerful tool for the identification and quantification of proteins from a wide variety of biological specimens. To date, the majority of studies utilizing tissue samples have been carried out on prospectively collected fresh frozen or opti...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6074037/ https://www.ncbi.nlm.nih.gov/pubmed/30087585 http://dx.doi.org/10.1186/s12014-018-9202-4 |
_version_ | 1783344324324360192 |
---|---|
author | Piehowski, Paul D. Petyuk, Vladislav A. Sontag, Ryan L. Gritsenko, Marina A. Weitz, Karl K. Fillmore, Thomas L. Moon, Jamie Makhlouf, Hala Chuaqui, Rodrigo F. Boja, Emily S. Rodriguez, Henry Lee, Jerry S. H. Smith, Richard D. Carrick, Danielle M. Liu, Tao Rodland, Karin D. |
author_facet | Piehowski, Paul D. Petyuk, Vladislav A. Sontag, Ryan L. Gritsenko, Marina A. Weitz, Karl K. Fillmore, Thomas L. Moon, Jamie Makhlouf, Hala Chuaqui, Rodrigo F. Boja, Emily S. Rodriguez, Henry Lee, Jerry S. H. Smith, Richard D. Carrick, Danielle M. Liu, Tao Rodland, Karin D. |
author_sort | Piehowski, Paul D. |
collection | PubMed |
description | BACKGROUND: Mass spectrometry-based proteomics has become a powerful tool for the identification and quantification of proteins from a wide variety of biological specimens. To date, the majority of studies utilizing tissue samples have been carried out on prospectively collected fresh frozen or optimal cutting temperature (OCT) embedded specimens. However, such specimens are often difficult to obtain, in limited in supply, and clinical information and outcomes on patients are inherently delayed as compared to banked samples. Annotated formalin fixed, paraffin embedded (FFPE) tumor tissue specimens are available for research use from a variety of tissue banks, such as from the surveillance, epidemiology and end results (SEER) registries’ residual tissue repositories. Given the wealth of outcomes information associated with such samples, the reuse of archived FFPE blocks for deep proteomic characterization with mass spectrometry technologies would provide a valuable resource for population-based cancer studies. Further, due to the widespread availability of FFPE specimens, validation of specimen integrity opens the possibility for thousands of studies that can be conducted worldwide. METHODS: To examine the suitability of the SEER repository tissues for proteomic and phosphoproteomic analysis, we analyzed 60 SEER patient samples, with time in storage ranging from 7 to 32 years; 60 samples with expression proteomics and 18 with phosphoproteomics, using isobaric labeling. Linear modeling and gene set enrichment analysis was used to evaluate the impacts of collection site and storage time. RESULTS: All samples, regardless of age, yielded suitable protein mass after extraction for expression analysis and 18 samples yielded sufficient mass for phosphopeptide analysis. Although peptide, protein, and phosphopeptide identifications were reduced by 50, 20 and 76% respectively, from comparable OCT specimens, we found no statistically significant differences in protein quantitation correlating with collection site or specimen age. GSEA analysis of GO-term level measurements of protein abundance differences between FFPE and OCT embedded specimens suggest that the formalin fixation process may alter representation of protein categories in the resulting dataset. CONCLUSIONS: These studies demonstrate that residual FFPE tissue specimens, of varying age and collection site, are a promising source of protein for proteomic investigations if paired with rigorously verified mass spectrometry workflows. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12014-018-9202-4) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-6074037 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-60740372018-08-07 Residual tissue repositories as a resource for population-based cancer proteomic studies Piehowski, Paul D. Petyuk, Vladislav A. Sontag, Ryan L. Gritsenko, Marina A. Weitz, Karl K. Fillmore, Thomas L. Moon, Jamie Makhlouf, Hala Chuaqui, Rodrigo F. Boja, Emily S. Rodriguez, Henry Lee, Jerry S. H. Smith, Richard D. Carrick, Danielle M. Liu, Tao Rodland, Karin D. Clin Proteomics Research BACKGROUND: Mass spectrometry-based proteomics has become a powerful tool for the identification and quantification of proteins from a wide variety of biological specimens. To date, the majority of studies utilizing tissue samples have been carried out on prospectively collected fresh frozen or optimal cutting temperature (OCT) embedded specimens. However, such specimens are often difficult to obtain, in limited in supply, and clinical information and outcomes on patients are inherently delayed as compared to banked samples. Annotated formalin fixed, paraffin embedded (FFPE) tumor tissue specimens are available for research use from a variety of tissue banks, such as from the surveillance, epidemiology and end results (SEER) registries’ residual tissue repositories. Given the wealth of outcomes information associated with such samples, the reuse of archived FFPE blocks for deep proteomic characterization with mass spectrometry technologies would provide a valuable resource for population-based cancer studies. Further, due to the widespread availability of FFPE specimens, validation of specimen integrity opens the possibility for thousands of studies that can be conducted worldwide. METHODS: To examine the suitability of the SEER repository tissues for proteomic and phosphoproteomic analysis, we analyzed 60 SEER patient samples, with time in storage ranging from 7 to 32 years; 60 samples with expression proteomics and 18 with phosphoproteomics, using isobaric labeling. Linear modeling and gene set enrichment analysis was used to evaluate the impacts of collection site and storage time. RESULTS: All samples, regardless of age, yielded suitable protein mass after extraction for expression analysis and 18 samples yielded sufficient mass for phosphopeptide analysis. Although peptide, protein, and phosphopeptide identifications were reduced by 50, 20 and 76% respectively, from comparable OCT specimens, we found no statistically significant differences in protein quantitation correlating with collection site or specimen age. GSEA analysis of GO-term level measurements of protein abundance differences between FFPE and OCT embedded specimens suggest that the formalin fixation process may alter representation of protein categories in the resulting dataset. CONCLUSIONS: These studies demonstrate that residual FFPE tissue specimens, of varying age and collection site, are a promising source of protein for proteomic investigations if paired with rigorously verified mass spectrometry workflows. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12014-018-9202-4) contains supplementary material, which is available to authorized users. BioMed Central 2018-08-03 /pmc/articles/PMC6074037/ /pubmed/30087585 http://dx.doi.org/10.1186/s12014-018-9202-4 Text en © The Author(s) 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Piehowski, Paul D. Petyuk, Vladislav A. Sontag, Ryan L. Gritsenko, Marina A. Weitz, Karl K. Fillmore, Thomas L. Moon, Jamie Makhlouf, Hala Chuaqui, Rodrigo F. Boja, Emily S. Rodriguez, Henry Lee, Jerry S. H. Smith, Richard D. Carrick, Danielle M. Liu, Tao Rodland, Karin D. Residual tissue repositories as a resource for population-based cancer proteomic studies |
title | Residual tissue repositories as a resource for population-based cancer proteomic studies |
title_full | Residual tissue repositories as a resource for population-based cancer proteomic studies |
title_fullStr | Residual tissue repositories as a resource for population-based cancer proteomic studies |
title_full_unstemmed | Residual tissue repositories as a resource for population-based cancer proteomic studies |
title_short | Residual tissue repositories as a resource for population-based cancer proteomic studies |
title_sort | residual tissue repositories as a resource for population-based cancer proteomic studies |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6074037/ https://www.ncbi.nlm.nih.gov/pubmed/30087585 http://dx.doi.org/10.1186/s12014-018-9202-4 |
work_keys_str_mv | AT piehowskipauld residualtissuerepositoriesasaresourceforpopulationbasedcancerproteomicstudies AT petyukvladislava residualtissuerepositoriesasaresourceforpopulationbasedcancerproteomicstudies AT sontagryanl residualtissuerepositoriesasaresourceforpopulationbasedcancerproteomicstudies AT gritsenkomarinaa residualtissuerepositoriesasaresourceforpopulationbasedcancerproteomicstudies AT weitzkarlk residualtissuerepositoriesasaresourceforpopulationbasedcancerproteomicstudies AT fillmorethomasl residualtissuerepositoriesasaresourceforpopulationbasedcancerproteomicstudies AT moonjamie residualtissuerepositoriesasaresourceforpopulationbasedcancerproteomicstudies AT makhloufhala residualtissuerepositoriesasaresourceforpopulationbasedcancerproteomicstudies AT chuaquirodrigof residualtissuerepositoriesasaresourceforpopulationbasedcancerproteomicstudies AT bojaemilys residualtissuerepositoriesasaresourceforpopulationbasedcancerproteomicstudies AT rodriguezhenry residualtissuerepositoriesasaresourceforpopulationbasedcancerproteomicstudies AT leejerrysh residualtissuerepositoriesasaresourceforpopulationbasedcancerproteomicstudies AT smithrichardd residualtissuerepositoriesasaresourceforpopulationbasedcancerproteomicstudies AT carrickdaniellem residualtissuerepositoriesasaresourceforpopulationbasedcancerproteomicstudies AT liutao residualtissuerepositoriesasaresourceforpopulationbasedcancerproteomicstudies AT rodlandkarind residualtissuerepositoriesasaresourceforpopulationbasedcancerproteomicstudies |